Skip to main content
. 2021 Jul 15;22(14):7561. doi: 10.3390/ijms22147561

Figure 2.

Figure 2

A delicate balance of the NOS/arginase activities in the human sinonasal system modifies the bioavailability of the NOS substrate based on CRS phenotypes. CRS: chronic rhinosinusitis; ECRS: eosinophilic chronic rhinosinusitis; NO: nitric oxide; NOS: nitric oxide synthase; ONOO−: peroxynitrite; O2: superoxide.